Tobias Abersfelder joins GSK Stockmann’s compliance and dispute resolution team

Tobias Abersfelder has joined GSK Stockmann’s Hamburg office as of 1 December as Counsel in the areas of compliance and investigations as well as dispute resolution. Abersfelder comes to GSK Stockmann from Eversheds Sutherland.

GSK Stockmann appoints seven new partners and two counsel from within its own ranks

At the Partners’ Meeting on 24 and 25 November 2023, GSK Stockmann appointed four new Equity Partners, three Local Partners and two Counsel from within its own ranks with effect from 1 January 2024. These promotions reflect the firm’s unwavering commitment to its strategy of supporting the professional development of its young lawyers and deploying …

Robert Korndörfer joins GSK Stockmann’s Berlin office as a new partner

GSK Stockmann is welcoming corporate M&A and private equity expert Robert Korndörfer as a new partner at the firm. From 1 November 2023, he will be joining the team at GSK’s Berlin office, where his expertise will support the further expansion of the firm’s advisory services in the areas of corporate M&A and private equity.

GSK Stockmann advises Diringer & Scheidel on the sale of the multi-use property New7 in Mannheim via a forward deal

GSK Stockmann advised the long-established family-owned company Diringer & Scheidel on the sale via a forward deal of the former Kaufhof building in Square N 7 in Mannheim.

New partner in Luxembourg: GSK Stockmann brings Anna Gassner on board

Anna Gassner will be joining GSK Stockmann’s team in Luxembourg as of 1 October 2023. The addition of a new partner is part of the firm’s strategy to further expand its advisory services in the areas of corporate M&A and private equity.

GSK Stockmann advises Sonar Real Estate on real estate acquisition in Stuttgart

The law firm assisted Hamburg-based Sonar Real Estate GmbH in acquiring a mixed-use building complex in Stuttgart-Vaihingen.

GSK Stockmann advises Isar Klinik Immobilien GmbH on property sale and land division

GSK Stockmann advised Munich-based Isar Klinik Immobilien GmbH on the land division and sale of an office property in the centre of Munich to CDC Investissement Immobilier and the FOM Real Estate Group.

GSK Stockmann advises FONDSGRUND on the acquisition of the 28,500 sqm “Netzwerk” property in Regensburg for an HIH Invest fund

A GSK Stockmann team led by Michael Jani provided comprehensive advice on real estate, tax, investment and insurance law to the Hamburg-based investment and asset manager FONDSGRUND Investment in connection with the acquisition of the “Netzwerk” office property in Regensburg for HIH Invest Real Estate and a club of German institutional investors.

GSK Stockmann advises Pohl-Boskamp on mynoise acquisition

GSK Stockmann advised G. Pohl-Boskamp GmbH & Co. KG based in Hohenlockstedt in Schleswig-Holstein on the acquisition of Duisburg-based mynoise GmbH. The acquisition allows Pohl-Boskamp to expand its business in the field of digital health applications and protects the future of the Kalmeda® tinnitus app, which was developed by mynoise.

GSK Stockmann advises Evonik on the sale of its Lülsdorf plant

Evonik is selling its German production plant in Lülsdorf and the associated cyanuric chloride business in nearby Wesseling to the International Chemical Investors Group (ICIG).